BioNTech SE (BNTX)
BioNTech SE Revenue
| Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0 | $69.6M | $150.6M | $121.6M | $550.7M | $22.4B | $18.2B | $4,129.8M |
BioNTech SE (BNTX) Revenue comparison analysis
BNTX key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is BioNTech SE's Revenue?
As of today, BioNTech SE's last 12-month Revenue is $3,298.6M, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is BioNTech SE's Revenue growth rate?
Over the last year, BioNTech SE's Revenue growth was (53.3%). The average annual Revenue growth rates for BioNTech SE have been 4.1% over the past three years, 82.5% over the past five years.
3) Is BioNTech SE's Revenue growth rate Good?
Over the last year, BioNTech SE's Revenue growth was (53.3%), which is lower than industry growth of 3.1%. It indicates that BioNTech SE's Revenue growth is Bad.